2025 Sponsors
Major Gold Sponsors
At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love.
With headquarters in north suburban Chicago, we serve people in more than 160 countries with leading medical devices, diagnostics, nutrition products and branded generic medicines. Our 113,000 colleagues are helping millions of people to live better and healthier, every day around the world.
Novo Nordisk's purpose is to drive change to defeat serious chronic diseases, built upon its heritage in diabetes.
The company pioneers scientific breakthroughs, expands access to medicines, and works to prevent and ultimately cure the diseases it treats.
Lions Australia Diabetes Foundation
Formerly known as the Lions District 201N3 Diabetes Foundation, the Foundation was constituted by a resolution of the 1992 District 201N3 Convention, is governed by a Trust Deed and supported by Lions, Lioness and Leos clubs from every District in Australia. The principal aims of the Foundation are to fund research into the causes and treatment of diabetes, raise awareness, and provide education to improve care and support for people who have diabetes or are at risk of developing the condition.
This foundation has generously sponsored a PhD thesis dedicated to the physical activity lifestyle module within the Diabetes Alliance Program Plus (DAP+). This research aims to systematically review and synthesise evidence on physical activity interventions in primary care settings. Additionally, it seeks to explore the barriers and facilitators of implementation strategies for these interventions, focusing on the uptake of the ecofit physical activity program among adult patients diagnosed with type II diabetes. The PhD thesis will also evaluate implementation outcomes of the ecofit program, such as its reach, uptake, and effectiveness, for both primary care clinicians and patients with type II diabetes.
Event Sponsors
embecta (formerly BD Diabetes Care) is a pure play diabetes company committed to accelerating the journey to better diabetes care. Starting with the creation of the first insulin syringe in 1924, we specialise in injection technologies and present over 100 years in product innovation and care. We’re by your side as your partner for reliable, innovative and trusted diabetes care solutions.